Serum YKL-40 positively correlates with MMP-9 and CRP in patients with acute ST segment elevation myocardial infarction following emergency treatment
Authors:
- Xiaoying JiXJXiaoying Ji
- Zhifeng MoZMZhifeng Mo
- Yaoliang ZhouYZYaoliang Zhou
Open Access
- 1 November 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (47) , e17950
Abstract
Objective: To investigate the role of YKL-40 in ST segment elevation myocardial infarction (STEMI) and its relationship to C-reactive protein (CRP) and matrix metalloproteinase-9 (MMP-9). Methods: This prospective study included 358 STEMI patients who were sent to the Emergency Department of our hospital from April 2014 to December 2017. Serum levels of YKL-40, CRP and MMP-9 were determined using commercially available Enzyme linked immunosorbent assay (ELISA) kits. Major adverse cardiovascular events (MACE) and overall survival time were analyzed. Results: GRACE scores (P < .001) and the levels of YKL-40 (P < .001), MMP-9 (P < .001), and CRP (P < .001) were significantly higher in deceased patients compared to those that survived. The levels of CRP (P = .007) and MMP-9 (P = .022) were significantly higher in the high YKL-40 group. The GRACE scores were also significantly elevated (P = .011, 95% CI 2.1 (−9.7 to −1.3)). Cumulative MACE rates and cardiac death rates were significantly higher in the high YKL-40 group (P < .001, 95% CI 3.9 (1.9–8.2)). Overall survival times were significantly longer in patients with lower YKL-40 levels (P < .0001). Conclusion: Elevated YKL-40 levels positively correlate with CRP and MMP-9 levels and are associated with clinical outcomes including MACE and 6-month survival in STEMI patients.Keywords
This publication has 29 references indexed in Scilit:
- Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapyTrials, 2013
- Researchers’ perceptions of ethical challenges in cluster randomized trials: a qualitative analysisTrials, 2013
- Echocardiographic predictors of early in-hospital heart failure during first ST-elevation acute myocardial infarction: does myocardial performance index and left atrial volume improve diagnosis over conventional parameters of left ventricular function?Cardiovascular Ultrasound, 2011
- Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort StudyPLOS ONE, 2011
- Changing patterns of ST elevation myocardial infarction epidemiologyAmerican Heart Journal, 2010
- YKL-40 - an emerging biomarker in cardiovascular disease and diabetesCardiovascular Diabetology, 2009
- Impact of Ultrasensitive Cardiac Troponin I Dynamic Changes in the New Universal Definition of Myocardial InfarctionAmerican Journal of Clinical Pathology, 2008
- Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin TEuropean Heart Journal, 2008
- YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery diseaseScandinavian Cardiovascular Journal, 2008
- Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancerActa Obstetricia et Gynecologica Scandinavica, 2003